Cerebrospinal Fluid Amyloid β1–42 Levels in the Mild Cognitive Impairment Stage of Alzheimer's Disease
暂无分享,去创建一个
H. Arai | S. Higuchi | M. Higuchi | N. Okamura | Hidetada Sasaki | H. Tanji | T. Matsui | M. Maruyama | S. Matsushita | H. Yoshida | M. Sugita
[1] K. Davis,et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. , 2000, JAMA.
[2] K. Blennow,et al. Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment , 1999, Neuroscience Letters.
[3] B Engvall,et al. Cerebrospinal fluid Aβ42 is increased early in sporadic Alzheimer's disease and declines with disease progression , 1999, Annals of neurology.
[4] Giovanni B. Frisoni,et al. Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' , 1998 .
[5] D. Galasko,et al. Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease , 1997, Neurology.
[6] M. Higuchi,et al. ELEVATED CEREBROSPINAL FLUID TAU LEVELS: IMPLICATIONS FOR THE EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE , 1996, Journal of the American Geriatrics Society.
[7] A. Kurz,et al. Cerebrospinal protein tau is elevated in early Alzheimer's disease , 1996, Neuroscience Letters.
[8] J. Morris,et al. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[9] P. S. St George-Hyslop,et al. Prediction of probable Alzheimer's disease in memory-impaired patients , 1996, Neurology.
[10] J. Trojanowski,et al. Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease , 1995, Annals of neurology.
[11] D. Schaid,et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.
[12] PhilipR. Wenham,et al. Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.
[13] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[14] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[15] K. Blennow,et al. Development of a Specific Diagnostic Test for Measurement of β-Amyloid (1-42) [βA4(l-42)] in CSF , 1998 .
[16] B. Winblad,et al. Mild cognitive impairment--an early stage of Alzheimer's disease? , 1998, Journal of neural transmission. Supplementum.
[17] A. Fisher,et al. Progress in Alzheimer’s and Parkinson’s Diseases , 1998, Advances in Behavioral Biology.